Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience
- PMID: 24311021
- DOI: 10.1001/jamapediatrics.2013.4342
Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience
Abstract
Importance: To verify the elimination of endemic measles, rubella, and congenital rubella syndrome (CRS) from the Western hemisphere, the Pan American Health Organization requested each member country to compile a national elimination report. The United States documented the elimination of endemic measles in 2000 and of endemic rubella and CRS in 2004. In December 2011, the Centers for Disease Control and Prevention convened an external expert panel to review the evidence and determine whether elimination of endemic measles, rubella, and CRS had been sustained.
Objective: To review the evidence for sustained elimination of endemic measles, rubella, and CRS from the United States through 2011.
Design, setting, and participants: Review of data for measles from 2001 to 2011 and for rubella and CRS from 2004 to 2011 covering the US resident population and international visitors, including disease epidemiology, importation status of cases, molecular epidemiology, adequacy of surveillance, and population immunity as estimated by national vaccination coverage and serologic surveys.
Main outcomes and measures: Annual numbers of measles, rubella, and CRS cases, by importation status, outbreak size, and distribution; proportions of US population seropositive for measles and rubella; and measles-mumps-rubella vaccination coverage levels.
Results: Since 2001, US reported measles incidence has remained below 1 case per 1,000,000 population. Since 2004, rubella incidence has been below 1 case per 10,000,000 population, and CRS incidence has been below 1 case per 5,000,000 births. Eighty-eight percent of measles cases and 54% of rubella cases were internationally imported or epidemiologically or virologically linked to importation. The few cases not linked to importation were insufficient to represent endemic transmission. Molecular epidemiology indicated no endemic genotypes. The US surveillance system is adequate to detect endemic measles or rubella. Seroprevalence and vaccination coverage data indicate high levels of population immunity to measles and rubella.
Conclusions and relevance: The external expert panel concluded that the elimination of endemic measles, rubella, and CRS from the United States was sustained through 2011. However, international importation continues, and health care providers should suspect measles or rubella in patients with febrile rash illness, especially when associated with international travel or international visitors, and should report suspected cases to the local health department.
Comment in
-
The beginning of the end of measles and rubella.JAMA Pediatr. 2014 Feb;168(2):108-9. doi: 10.1001/jamapediatrics.2013.4603. JAMA Pediatr. 2014. PMID: 24310954 No abstract available.
Similar articles
-
Approach to verify the status of measles, rubella, and congenital rubella syndrome elimination in Costa Rica.J Infect Dis. 2011 Sep 1;204 Suppl 2:S690-7. doi: 10.1093/infdis/jir478. J Infect Dis. 2011. PMID: 21954268
-
Elimination of rubella and congenital rubella syndrome--United States, 1969-2004.MMWR Morb Mortal Wkly Rep. 2005 Mar 25;54(11):279-82. MMWR Morb Mortal Wkly Rep. 2005. PMID: 15788995
-
Measles, rubella, and congenital rubella syndrome--United States and Mexico, 1997-1999.MMWR Morb Mortal Wkly Rep. 2000 Nov 24;49(46):1048-50, 1059. MMWR Morb Mortal Wkly Rep. 2000. PMID: 11105768
-
Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience.J Infect Dis. 2003 May 15;187 Suppl 1:S158-63. doi: 10.1086/368053. J Infect Dis. 2003. PMID: 12721908 Review.
-
Congenital rubella syndrome: a matter of concern.Rev Panam Salud Publica. 2015 Mar;37(3):179-86. Rev Panam Salud Publica. 2015. PMID: 25988255 Review.
Cited by
-
Modeling vaccination coverage during the 2022 central Ohio measles outbreak: a cross-sectional study.Lancet Reg Health Am. 2023 Jun 27;23:100533. doi: 10.1016/j.lana.2023.100533. eCollection 2023 Jul. Lancet Reg Health Am. 2023. PMID: 37497395 Free PMC article.
-
Predicting Measles Outbreaks in the United States: Evaluation of Machine Learning Approaches.JMIR Form Res. 2023 Apr 4;7:e42832. doi: 10.2196/42832. JMIR Form Res. 2023. PMID: 37014694 Free PMC article.
-
Past as Prologue-Use of Rubella Vaccination Program Lessons to Inform COVID-19 Vaccination.Emerg Infect Dis. 2022 Dec;28(13):S225-S231. doi: 10.3201/eid2813.220604. Emerg Infect Dis. 2022. PMID: 36502405 Free PMC article. Review.
-
Morbilliform Eruptions in the Hospitalized Child.Dermatol Clin. 2022 Apr;40(2):191-202. doi: 10.1016/j.det.2021.12.006. Epub 2022 Mar 4. Dermatol Clin. 2022. PMID: 35366972 Free PMC article. Review.
-
The Clinical and Economic Impact of Measles-Mumps-Rubella Vaccinations to Prevent Measles Importations From US Pediatric Travelers Returning From Abroad.J Pediatric Infect Dis Soc. 2022 Jun 22;11(6):257-266. doi: 10.1093/jpids/piac011. J Pediatric Infect Dis Soc. 2022. PMID: 35333347 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
